Literature DB >> 9314081

MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses.

E G Pamer1, A J Sijts, M S Villanueva, D H Busch, S Vijh.   

Abstract

Listeria monocytogenes (L. monocytogenes) secretes proteins associated with its virulence into the cytosol of infected cells. These secreted proteins are degraded by host cell proteasomes and processed into peptides that are bound by MHC class I molecules in the endoplasmic reticulum. We have found that the MHC class I antigen-processing pathway is very efficient at generating the epitopes that are presented to cytolytic T lymphocytes (CTL). Depending on which antigen is investigated, from 3 to 30% of degraded antigens are processed into nonamer peptides that are bound by MHC class I molecules. Surprisingly, neither the efficiency of epitope generation nor the absolute number of epitopes per infected cell determines the magnitude of the in vivo CTL response. One of the least prevalent epitopes, derived from an antigen that is virtually undetectable in infected cells, primes the immunodominant CTL response in L. monocytogenes-infected mice. Our studies suggest that immunodominant and subdominant T-cell responses cannot be predicted by the prevalence of antigens or epitopes alone, and that additional factors, yet to be determined, are involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314081     DOI: 10.1111/j.1600-065x.1997.tb00999.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  24 in total

Review 1.  Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.

Authors:  Yvonne Paterson; Patrick D Guirnalda; Laurence M Wood
Journal:  Semin Immunol       Date:  2010-03-17       Impact factor: 11.130

2.  Salmonella pathogenicity island 2-mediated overexpression of chimeric SspH2 proteins for simultaneous induction of antigen-specific CD4 and CD8 T cells.

Authors:  Klaus Panthel; Katrin M Meinel; Victòria E Sevil Domènech; Heike Retzbach; Emeka I Igwe; Wolf-Dietrich Hardt; Holger Rüssmann
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Concomitant cytosolic delivery of two immunodominant listerial antigens by Salmonella enterica serovar typhimurium confers superior protection against murine listeriosis.

Authors:  Emeka I Igwe; Gernot Geginat; Holger Rüssmann
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Attenuated Listeria monocytogenes as a cancer vaccine vector for the delivery of CD24, a biomarker for hepatic cancer stem cells.

Authors:  Yu Yang; Jiajie Hou; Zhe Lin; Han Zhuo; Dianyu Chen; Xudong Zhang; Yun Chen; Beicheng Sun
Journal:  Cell Mol Immunol       Date:  2014-02-03       Impact factor: 11.530

5.  Processing and major histocompatibility complex class II presentation of Legionella pneumophila antigens by infected macrophages.

Authors:  Annie Neild; Takahiro Murata; Craig R Roy
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.

Authors:  Hans Joachim Mollenkopf; Leander Grode; Jens Mattow; Maik Stein; Peggy Mann; Bernhard Knapp; Jeffrey Ulmer; Stefan H E Kaufmann
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+FoxP3- and CD8+ T cells.

Authors:  Zhisong Chen; Laurent Ozbun; Namju Chong; Anu Wallecha; Jay A Berzofsky; Samir N Khleif
Journal:  Cancer Immunol Res       Date:  2014-05-28       Impact factor: 11.151

8.  Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathway.

Authors:  Benjamin J Wolf; Michael F Princiotta
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

Review 9.  Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines.

Authors:  Rui Sun; Yuqin Liu
Journal:  Hum Vaccin Immunother       Date:  2013-02-11       Impact factor: 3.452

10.  Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization.

Authors:  Waleed Mustafa; Paulo Cesar Maciag; Zhen-kun Pan; Jessica R Weaver; Yuhong Xiao; Stuart N Isaacs; Yvonne Paterson
Journal:  Viral Immunol       Date:  2009-06       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.